- Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?2023 | Second Faculty of Medicine
- Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy2022 | Second Faculty of Medicine
- Treatment decisions in chronic myeloid leukemia in the view of BCR-ABL1 mutations in practice2010 | Faculty of Medicine in Hradec Králové
- ABL1, SRC and other non-receptor tyrosine-kinases as new targets for specific anticancer therapy2010 | First Faculty of Medicine
- Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease2022 | Second Faculty of Medicine